Tag: venture capital
-
FDA Clears Digital Health Monitoring System
A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use.
-
Mental Health Therapy, Tech Network Gains Early Funds
A company building a therapy and technology network for improving access to mental health providers is raising $15 million in its first venture round.
-
Residual Cancer Detection Company Launches, Raises $56M
A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds.
-
Infographic – US, China Lead in Space Investments
Data collected by Space Capital, a venture investor in companies developing space-based technologies, shows $265 billion invested in these start-up companies since 2014.
-
Cancer Detection Start-Up Gains $4M in Seed Funds
A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round.
-
Immunotherapy Start-Up Launches Collaboration, Raises $65M
A new biotechnology company is creating cancer immunotherapies that it says harness more of the full power of T-cells in the immune system to attack tumors.
-
Infographic – Q3 Digital Health Venture Funds Slide
Venture funding for start-ups worldwide applying digital technologies to health care continued to fall in the third quarter of 2022, both in deals and dollars invested.
-
“Dark Genome” Drug Discoverer Gains $37M in Early Funds
19 Oct. 2022. A biotechnology enterprise discovering new drugs from non-protein coding regions of the genome is raising €37.5 million ($US 36.6 million) in venture funds. Nucleome Therapeutics Ltd. in Oxford, U.K. is a three year-old business spun-off from genetic research labs at University of Oxford medical school. Nucleome Therapeutics is seeking new treatments for…
-
Infographic – US Biotech Venture Funds Fall in Q3
Venture funds for U.S. biotechnology and pharmaceutical start-ups declined in the third quarter of 2022 from the 2021 record pace, but remain on track for historic highs.
-
Hydrogel Biomaterials Company Raises $3M in Early Funds
A developer of bioactive hydrogels as alternatives to animal models for drug discovery and clinical lab tests is raising $3 million in its first venture round.